Compugen Ltd (CGEN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4400 -0.0400 (-2.70%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4400 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | CGEN | ADCT | SCPH | ||
Company | Compugen Ltd | Adc Therapeutics Sa | SC Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | ||
Open | 1.4400 | 1.4600 | 2.53 | ||
High | 1.4700 | 1.5000 | 2.62 | ||
Low | 1.4200 | 1.3650 | 2.41 | ||
Last | 1.4400 | 1.4600 | 2.45 | ||
Change | -0.0400 | +0.1300 | -0.06 | ||
% Change | -2.70% | +9.77% | -2.39% | ||
Volume | 75,200 | 410,000 | 101,100 | ||
20-Day Average Volume | 250,070 | 340,870 | 455,710 | ||
Previous Close | 1.4800 | 1.3300 | 2.51 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.3770 | 1.2505 | 2.43 | ||
20-Day Raw Stochastic | 77.50% | 91.11% | 61.82% | ||
20-Day Relative Strength | 45.69% | 51.73% | 42.55% | ||
Weighted Alpha | -42.99 | -60.22 | -48.77 | ||
Today's Opinion | 72% Sell | 88% Sell | 88% Sell | ||
Previous Opinion | 72% Sell | 88% Sell | 88% Sell | ||
Last Month's Opinion | 56% Sell | 88% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +3.60% since 04/21/25 | +18.70% since 04/21/25 | -4.30% since 04/21/25 | ||
Low | 1.3800 on 04/22/25 | 1.2000 on 04/22/25 | 2.37 on 04/25/25 | ||
High | 1.5200 on 04/25/25 | 1.5000 on 04/28/25 | 2.76 on 04/23/25 | ||
1-Month | |||||
%Chg | -5.88% since 03/28/25 | -2.01% since 03/28/25 | -11.71% since 03/28/25 | ||
Low | 1.1300 on 04/09/25 | 1.0500 on 04/09/25 | 1.94 on 04/09/25 | ||
High | 1.5300 on 04/03/25 | 1.5000 on 04/28/25 | 2.77 on 03/31/25 | ||
3-Month | |||||
%Chg | -37.12% since 01/28/25 | -15.12% since 01/28/25 | -25.08% since 01/28/25 | ||
Low | 1.1300 on 04/09/25 | 1.0500 on 04/09/25 | 1.94 on 04/09/25 | ||
High | 2.6600 on 02/10/25 | 1.9100 on 03/12/25 | 3.87 on 02/13/25 | ||
6-Month | |||||
%Chg | -14.79% since 10/28/24 | -52.29% since 10/28/24 | -43.94% since 10/28/24 | ||
Low | 1.1300 on 04/09/25 | 1.0500 on 04/09/25 | 1.94 on 04/09/25 | ||
High | 2.6600 on 02/10/25 | 3.4900 on 12/10/24 | 4.60 on 10/30/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 116,900 | 117,030 | 116,659 | ||
Shares Outstanding, K | 89,237 | 99,178 | 50,284 | ||
Annual Sales | 27,860,000 | 70,840,000 | 36,330,000 | ||
Annual Net Income | -14,230,000 | -157,850,000 | -85,150,000 | ||
Last Quarter Sales | 1,470,000 | 16,910,000 | 12,150,000 | ||
Last Quarter Net Income | -6,120,000 | -30,730,000 | -18,850,000 | ||
60-Month Beta | 3.19 | 1.55 | 0.38 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.07 on 03/04/25 | -0.29 on 03/27/25 | -0.35 on 03/19/25 | ||
Latest Earnings Date | 05/19/25 | 05/05/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |